EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Urine and Plasma Extracellular Vesicle Analysis for Monitoring Renal Recovery after Acute Kidney Injury

Adele Tanzi, Cristina Grange, Miriam Rosina, Alessia Brossa, Jacopo Burrello, Sarah Tassinari, Stefania Prenna, Riccardo Piscia, Valentina Bettio, Daniela Capello, Marita Marengo, Vincenzo Cantaluppi, Benedetta Bussolati

Kidney360 · 2026-10 · 7 (10) · 2175-2185

DOI: 10.34067/kid.0000001331 ↗
AbstractBibliografische Angaben

Abstract

Key Points Surface expression of stage-specific embryonic antigen 4 on urinary extracellular vesicles and CD42a on plasma extracellular vesicles identified distinct recovery trajectories after AKI. A combined urinary–plasma extracellular vesicle index enhanced prognostic performance. These findings highlight extracellular vesicle surface profiling as a potential minimally invasive liquid biopsy strategy to monitor post-AKI repair. Background Maladaptive repair processes after AKI can promote the progression of CKD, highlighting the need for biomarkers capable of monitoring post-AKI renal function trajectory. Extracellular vesicles (EVs), nanosized lipid vesicles secreted by cells into biofluids, are considered valuable biomarker sources, as their cargo may reflect the originating cells and their pathophysiologic condition. Methods Urinary EV (uEV) and plasma EV surface markers were analyzed in patients with AKI compared with age- and sex-matched controls using multiplex flow cytometry. Patients were stratified according to renal function changes at 90-day follow-up, distinguishing between those with an improved or not-improved kidney disease. Results In patients with AKI at hospital discharge, uEV analysis showed a downregulation of the tubular progenitor markers CD133 and CD24, with upregulation of mesenchymal/inflammatory markers CD29, stage-specific embryonic antigen 4 (SSEA-4), and HLA-DR, in comparison with controls. Plasma EV analysis showed concomitant modulation in patients with AKI of markers of endothelial dysfunction and platelet activation. Considering kidney function at 90 days of follow-up, uEVSSEA-4, a marker of cell dedifferentiation, was higher in patients with AKI with improved function and correlated with renal recovery. Conversely, plasma EV CD42a, a marker of platelet activation, was higher in patients with persistent renal impairment and negatively correlated with renal recovery. Furthermore, the combined urinary SSEA4/plasma EV-associated CD42a index provided higher correlation and regression performance compared with either marker alone. Conclusions These findings suggest that EV surface profiling could represent a minimally invasive strategy to distinguish adaptive from maladaptive repair after AKI, supporting the potential use of integrated uEV and plasma EV biomarkers to predict kidney disease progression. Podcast This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2026_10_29_KID0000001331.mp3

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →